蒽环类药物心脏毒性及其预防措施  

Anthracycline cardiotoxicity and its preventive measures

作　　者：庄艳[1] 刘先领[2] 

机构地区：[1]海南省人民医院肿瘤内科,海南海口570206 [2]中南大学湘雅二医院肿瘤内科,湖南长沙410011

出　　处：《肿瘤药学》2011年第4期322-326,共5页Anti-Tumor Pharmacy

摘　　要：蒽环类抗癌药是对多种恶性肿瘤具有高效作用的化疗药物,但由于其心脏毒性,在临床上受到使用限制。本文将就蒽环类药物心脏毒性的临床特点、发生机制、临床检测及预防措施作一综述。Anthracycline Anticancer Drugs were effective chemotherapy to a variety of cancers,however,Anthracycline Anticancer Drugs were restricted by its cardiotoxicity.This article would review on the clinical characteristics,mechanism,clinical advances,clinical detection and preventive measures.

关 键 词：蒽环类药物 阿霉素 心脏毒性 

分 类 号：R979.14[医药卫生—药品]